Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.12 Million USD | -87.41% |
| 2022 | -7 Million USD | -239.26% |
| 2021 | -2.06 Million USD | -26.98% |
| 2020 | -1.62 Million USD | -2947.77% |
| 2019 | -53.34 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -1.57 Million USD | 53.79% |
| 2023 Q1 | -3.41 Million USD | 31.52% |
| 2023 FY | -13.12 Million USD | -87.41% |
| 2023 Q4 | -6.97 Million USD | -215.62% |
| 2023 Q3 | -2.21 Million USD | -40.22% |
| 2022 Q4 | -4.98 Million USD | -374.99% |
| 2022 Q3 | -1.04 Million USD | -992.56% |
| 2022 Q2 | -96 Thousand USD | 89.05% |
| 2022 FY | -7 Million USD | -239.26% |
| 2022 Q1 | -876.98 Thousand USD | -32.93% |
| 2021 Q1 | -334.43 Thousand USD | -25.7% |
| 2021 FY | -2.06 Million USD | -26.98% |
| 2021 Q4 | -659.72 Thousand USD | -79.61% |
| 2021 Q3 | -367.3 Thousand USD | 25.79% |
| 2021 Q2 | -494.96 Thousand USD | -48.0% |
| 2020 FY | -1.62 Million USD | -2947.77% |
| 2020 Q4 | -266.06 Thousand USD | 0.0% |
| 2019 FY | -53.34 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 127.258% |
| Embecta Corp. | 70.4 Million USD | 118.645% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 169.898% |
| Dynavax Technologies Corporation | -6.38 Million USD | -105.448% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 93.727% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 131.286% |
| PainReform Ltd. | -9.34 Million USD | -40.476% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -66.786% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -191.299% |
| SCYNEXIS, Inc. | 67.04 Million USD | 119.579% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -323.623% |
| Cosmos Health Inc. | -18.54 Million USD | 29.211% |
| Journey Medical Corporation | -3.85 Million USD | -240.672% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -191.299% |
| Safety Shot Inc | -15.08 Million USD | 12.975% |
| Alpha Teknova, Inc. | -36.78 Million USD | 64.312% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 90.602% |
| Bright Green Corporation | -13.12 Million USD | 0.012% |
| Procaps Group, S.A. | 42.54 Million USD | 130.856% |
| Theratechnologies Inc. | -23.95 Million USD | 45.21% |
| Harrow Health, Inc. | -24.41 Million USD | 46.229% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -171.48% |
| Biofrontera Inc. | -20.13 Million USD | 34.797% |
| DURECT Corporation | -27.62 Million USD | 52.483% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 1097.423% |
| Cronos Group Inc. | -73.96 Million USD | 82.253% |
| OptiNose, Inc. | -35.48 Million USD | 63.007% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 98.69% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 68.895% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 154.884% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 365.441% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 8405.911% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -109.037% |
| Radius Health, Inc. | -25.79 Million USD | 49.106% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -112.98% |
| ProPhase Labs, Inc. | -16.78 Million USD | 21.785% |
| Phibro Animal Health Corporation | 2.41 Million USD | 643.298% |
| Procaps Group S.A. | 42.54 Million USD | 130.856% |
| Alvotech | -551.73 Million USD | 97.621% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -27.71% |
| Viatris Inc. | 54.7 Million USD | 123.996% |
| Rockwell Medical, Inc. | -8.43 Million USD | -55.541% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 17.154% |
| SIGA Technologies, Inc. | 68.06 Million USD | 119.284% |
| Tilray Brands, Inc. | -244.98 Million USD | 94.642% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 209.266% |
| Shineco, Inc. | -22.44 Million USD | 41.529% |
| PetIQ, Inc. | 2.13 Million USD | 715.959% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -205.127% |
| Incannex Healthcare Limited | -18.45 Million USD | 28.891% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 105.257% |
| Alimera Sciences, Inc. | -20.13 Million USD | 34.8% |
| Silver Spike Investment Corp. | 7.34 Million USD | 278.827% |
| Assertio Holdings, Inc. | -331.94 Million USD | 96.046% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -99.1% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -60.796% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 26.666% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 34.557% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 91.81% |
| Talphera, Inc. | -18.39 Million USD | 28.651% |
| Alvotech | -551.73 Million USD | 97.621% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 136.828% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 104.018% |
| Currenc Group, Inc. | -15.3 Million USD | 14.245% |
| Kamada Ltd. | 8.28 Million USD | 258.451% |
| Indivior PLC | 2 Million USD | 756.304% |
| Evoke Pharma, Inc. | -7.79 Million USD | -68.449% |
| Flora Growth Corp. | -57.03 Million USD | 76.986% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 34.557% |
| Evolus, Inc. | -61.68 Million USD | 78.721% |
| HUTCHMED (China) Limited | 100.78 Million USD | 113.024% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 109.543% |
| Akanda Corp. | -32.27 Million USD | 59.331% |